CVS Health

Recent news

• TD Cowen Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $110
  Market Newswire · 2026/10/9
• Rating change
  Piper Sandler Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $113
  Market Newswire · 2026/8/26
• Company notice
  CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Joyner J. David
  SEC · 2026/4/3
• Company notice
  CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Khichi Samrat S.
  SEC · 2026/4/3
• Company notice
  CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Shulman Douglas H.
  SEC · 2026/5/16
• RBC Capital Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $113
  Market Newswire · 2026/10/9
• Leerink Partners Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $112
  Market Newswire · 2026/10/12
• Rating change
  Wells Fargo Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $123
  Market Newswire · 2026/9/16
• Rating change
  Evercore Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $125
  Market Newswire · 2026/10/2
• Rating change
  Bernstein Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $106
  Market Newswire · 2026/9/9
• Rating change
  Jefferies Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $120
  Market Newswire · 2026/8/31
• BofA Securities Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $110
  Market Newswire · 2026/10/13
• BofA Securities Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $110
  Market Newswire · 2026/10/6
• Rating change
  Jefferies Maintains CVS GROUP PLC(CVSGF.US) With Hold Rating, Raises Target Price to $18.55
  Market Newswire · 2026/9/25
• Company notice
  CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Finucane Anne A.
  SEC · 2026/5/16
• Rating change
  Barclays Maintains CVS GROUP PLC(CVSGF.US) With Buy Rating, Cuts Target Price to $21.16
  Market Newswire · 2026/9/29
• Rating change
  UBS Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $118
  Market Newswire · 2026/9/3
• Company notice
  CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Balser Jeffrey R.
  SEC · 2026/5/16
• Rating change
  BofA Securities Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $120
  Market Newswire · 2026/9/15
• Rating change
  Bernstein Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $112
  Market Newswire · 2026/10/5
• CVS Bay Area Inc Cuts 1H Parent Pretax View to Y5.00M
  Dow Jones · 2026/10/8
• CVS Bay Area Inc Cuts FY Parent Pretax View to Y129.00M
  Dow Jones · 2026/10/8
• CVS Bay Area Inc Sees 1H Parent Pretax Y81.00M
  Dow Jones · 2026/10/8
• Rating change
  Morgan Stanley Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $111
  Market Newswire · 2026/8/10
• Rating change
  TD Cowen Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $110
  Market Newswire · 2026/8/26

Headlines are aggregated automatically and are not independently verified or edited by our team.